Katy Medical and Shenghe Pharmaceuticals signed a strategic cooperation agreement Nanjing Katy Medical April 16, 2020, April 15, 2020, Nanjing Katy Medical Technology Co., Ltd. (hereinafter referred to as Katy Medical) and Nanjing Shenghe Pharmaceutical Co., Ltd. (Hereinafter referred to as Shenghe Pharmaceutical) signed a strategic cooperation agreement in the Medical Valley of Jiangbei New Area, Nanjing. Chairman Wang Enxiu of Kati Medicine, Deputy General Manager of Shenghe Pharmaceutical and Dean of Research Institute Zhao Liwen signed a strategic cooperation agreement on behalf of both companies, and Luo Shuqin, Deputy Director of Life and Health Office of Jiangbei New District, Nanjing witnessed the signing.

Congratulations on the successful conclusion of the 2020 BPIT Biopharmaceutical Innovation Technology Conference. Winning in Nanjing·The Future of Science and Technology Salutes the "Golden Decade" and witnesses the new goals and new milestones of China's innovative drugs! From July 20th to 21st, the 2020 BPIT Biopharmaceutical Innovation Technology Conference hosted by Nanjing Jiangbei New Area was grandly held. The guests gathered at the conference. Dr. Wang Enxiu, Chairman & CEO of our company, was invited to present a gluttonous feast in the field of biopharmaceuticals with academician Chen Kaixian and other leading domestic bio-innovative drugs and industry elites in the pharmaceutical field.